Natalizumab for induction of remission in Crohn's disease (Cochrane Review)

How we can help you
To learn more about Update Software and how we can provide solutions for your data management and web & CD publication needs visit our home page.

Useful resources
The Reproductive Health Library: the best evidence in sexual and reproductive health.
Evidence-based Health Care Workbook and CD-ROM

New abstracts this issue

Search abstracts

Alphabetical list of abstracts

Abstracts by Review Group

Natalizumab for induction of remission in Crohn's disease (Cochrane Review)
MacDonald JK, McDonald JWD

ABSTRACT

Background: The pathogenesis of Crohn's disease involves migration of leukocytes into gut tissue and subsequent inflammation. Natalizumab (Tysabri®, Elan Pharmaceuticals and Biogen Idec) a recombinant humanized IgG4 monoclonal antibody that blocks adhesion and s . . .

Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com
Resources: WHO Reproductive Health Library, La Biblioteca Cochrane Plus, Renal Health Library, Malaria in Pregnancy Library
PubMed: Find related PubMed articles here [MacDonaldJK] [McDonaldJWD]
Google Scholar: Find related Google Scholar articles here [MacDonaldJK] [McDonaldJWD]